Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — Fertility

By Dr. Sherry LaBeck, ZRT Laboratory  In 2008 ZRT Laboratory introduced the Fertility Profile to assist women in identifying possible hormonal causes of infertility. More recently ZRT launched the Menstrual Cycle Mapping(MCM) test that allows women to map time points throughout their menstrual cycle, measuring levels of estrogen, progesterone and luteinizing hormone (LH). Since the MCM test was introduced there has been some confusion as to which test is best to evaluate fertility/infertility. The aim of this blog is to clarify the differences between the two tests and when best to use each. Menstrual Cycle Mapping The MCM profile measures...

If you are experiencing infertility issues, understanding which hormones to test — and why — is the essential first step. Dr. Alison McAllister of ZRT Laboratory explains the full fertility hormone profile: from LH and FSH as indicators of ovarian reserve, to estradiol, progesterone and testosterone for ovulation health, adrenal hormones cortisol and DHEA-S, thyroid markers including TPO antibodies, and the often-overlooked role of vitamin D in fertility and PCOS.

Infertility affects 1 in 8 couples worldwide — yet many are rushing into expensive IVF without first addressing the hormonal imbalances that may be silently undermining their chances. In this wide-ranging clinical discussion, Dr. Alison McAllister of ZRT Laboratory shares her expertise on the hormonal causes of infertility in both men and women, the key tests that are too often missed, and the complementary strategies that can dramatically improve outcomes.

The latest research confirms what Dr. John Lee and Dr. David Zava argued decades ago: maintaining healthy progesterone levels in proper balance with oestrogen is one of the most powerful tools women have for preventing and recovering from breast cancer. This article outlines seven practical steps to restore hormone balance and reduce breast cancer risk.

A landmark study published in Nature confirmed what Dr. John Lee and Dr. David Zava argued over a decade ago: natural progesterone — unlike synthetic progestins — can slow or even shrink ER+/PR+ breast cancer tumours. This article explains the receptor science behind the findings and what it means for women’s hormone health.